Publication | Open Access
Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy
73
Citations
37
References
2013
Year
NLR may serve as a potential biomarker for survival prognosis in patients with stage III-IV gastric cancer receiving neoadjuvant chemotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1